NEW YORK (360Dx) – Roche announced today that it has received US Food and Drug Administration approval for its Cobas c 513 analyzer and Tina-quant HbA1c Gen. 3 assay.

HbA1c is a form of hemoglobin used as measure of average plasma glucose concentration in the management of diabetes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.